by mfantozzi | Aug 27, 2021 | 2021, Press Releases, Scientific
We are pleased to announce that Philogen co-founder and CEO/CSO, Prof. Dario Neri is giving two lectures on September 1st, 2021: At the virtual International Symposium on Medicinal Chemistry (EFMC-ISMC 2021) Prof. Neri is giving a presentation at 15:35 (CEST) with the...by last | Aug 23, 2021 | 2021, Press Releases
Philochem, a wholly owned subsidiary of Philogen S.p.A., InterX, Inc and Scripps Research announce a research collaboration to develop a best-in-class tumor targeting agent for metastatic prostate cancer. Philochem, InterX and Scripps Research...by last | Aug 23, 2021 | 2021, Press Releases, Scientific
Philochem, a wholly owned subsidiary of Philogen S.p.A., InterX, Inc and Scripps Research announce a research collaboration to develop a best-in-class tumor targeting agent for metastatic prostate cancer. Read Moreby last | Aug 6, 2021 | 2021, Past Events
Philogen has been invited to participate at the Eleventh Annual Biotech Symposium organised by Goldman Sachs on September 7, 2021. The aim of the Symposium is to provide an opportunity for investors to get a broader perspective of the current opportunity set that...by last | Aug 6, 2021 | 2021, Past Events
Philogen has been invited to the Life Sciences Conference organised by KBC on September 7-9, 2021. The Conference provides an opportunity for investors to get a perspective of current opportunities and to meet CEO Dario Neri through a series of one-on-one meetings....by last | Aug 6, 2021 | 2021, Past Events
Philogen has been invited to participate at the 19th Annual Global Healthcare Conference organised by Morgan Stanley on September 9-15, 2021. The conference format includes virtual fireside chats for (C-level only) and one-on-one meetings, providing management the...